vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and Leonardo DRS, Inc. (DRS). Click either name above to swap in a different company.

Leonardo DRS, Inc. is the larger business by last-quarter revenue ($1.1B vs $719.4M, roughly 1.5× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 9.6%, a 63.6% gap on every dollar of revenue. On growth, Leonardo DRS, Inc. posted the faster year-over-year revenue change (8.1% vs 3.1%). Leonardo DRS, Inc. produced more free cash flow last quarter ($376.0M vs $357.0M). Over the past eight quarters, Leonardo DRS, Inc.'s revenue compounded faster (24.1% CAGR vs 8.9%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Leonardo DRS, Inc. is a United States–based defense contractor. Originally founded as DRS Technologies, Inc. and traded on the NYSE, it was acquired by Leonardo’s predecessor Finmeccanica in 2008. Leonardo DRS provides advanced defense technologies and systems primarily to the U.S. military.

DOC vs DRS — Head-to-Head

Bigger by revenue
DRS
DRS
1.5× larger
DRS
$1.1B
$719.4M
DOC
Growing faster (revenue YoY)
DRS
DRS
+5.0% gap
DRS
8.1%
3.1%
DOC
Higher net margin
DOC
DOC
63.6% more per $
DOC
73.2%
9.6%
DRS
More free cash flow
DRS
DRS
$19.0M more FCF
DRS
$376.0M
$357.0M
DOC
Faster 2-yr revenue CAGR
DRS
DRS
Annualised
DRS
24.1%
8.9%
DOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DOC
DOC
DRS
DRS
Revenue
$719.4M
$1.1B
Net Profit
$114.0M
$102.0M
Gross Margin
25.4%
Operating Margin
17.4%
11.9%
Net Margin
73.2%
9.6%
Revenue YoY
3.1%
8.1%
Net Profit YoY
2406.4%
14.6%
EPS (diluted)
$0.16
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
DRS
DRS
Q4 25
$719.4M
$1.1B
Q3 25
$705.9M
$960.0M
Q2 25
$694.3M
$829.0M
Q1 25
$702.9M
$799.0M
Q4 24
$698.0M
$981.0M
Q3 24
$700.4M
$812.0M
Q2 24
$695.5M
$753.0M
Q1 24
$606.6M
$688.0M
Net Profit
DOC
DOC
DRS
DRS
Q4 25
$114.0M
$102.0M
Q3 25
$-117.1M
$72.0M
Q2 25
$31.7M
$54.0M
Q1 25
$42.8M
$50.0M
Q4 24
$4.5M
$89.0M
Q3 24
$85.9M
$57.0M
Q2 24
$146.0M
$38.0M
Q1 24
$6.7M
$29.0M
Gross Margin
DOC
DOC
DRS
DRS
Q4 25
25.4%
Q3 25
58.6%
23.1%
Q2 25
60.2%
23.8%
Q1 25
61.1%
22.7%
Q4 24
60.3%
24.0%
Q3 24
60.0%
22.0%
Q2 24
60.6%
22.4%
Q1 24
59.8%
22.2%
Operating Margin
DOC
DOC
DRS
DRS
Q4 25
17.4%
11.9%
Q3 25
9.2%
9.7%
Q2 25
5.7%
8.4%
Q1 25
7.7%
7.4%
Q4 24
-2.2%
12.2%
Q3 24
14.1%
9.2%
Q2 24
22.3%
7.3%
Q1 24
3.7%
6.3%
Net Margin
DOC
DOC
DRS
DRS
Q4 25
73.2%
9.6%
Q3 25
-16.6%
7.5%
Q2 25
4.6%
6.5%
Q1 25
6.1%
6.3%
Q4 24
0.7%
9.1%
Q3 24
12.3%
7.0%
Q2 24
21.0%
5.0%
Q1 24
1.1%
4.2%
EPS (diluted)
DOC
DOC
DRS
DRS
Q4 25
$0.16
$0.38
Q3 25
$-0.17
$0.26
Q2 25
$0.05
$0.20
Q1 25
$0.06
$0.19
Q4 24
$0.02
$0.34
Q3 24
$0.12
$0.21
Q2 24
$0.21
$0.14
Q1 24
$0.01
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
DRS
DRS
Cash + ST InvestmentsLiquidity on hand
$467.5M
$647.0M
Total DebtLower is stronger
$9.8B
$321.0M
Stockholders' EquityBook value
$7.5B
$2.7B
Total Assets
$20.3B
$4.5B
Debt / EquityLower = less leverage
1.31×
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
DRS
DRS
Q4 25
$467.5M
$647.0M
Q3 25
$91.0M
$309.0M
Q2 25
$89.4M
$278.0M
Q1 25
$70.6M
$380.0M
Q4 24
$119.8M
$598.0M
Q3 24
$180.4M
$198.0M
Q2 24
$106.9M
$149.0M
Q1 24
$101.8M
$160.0M
Total Debt
DOC
DOC
DRS
DRS
Q4 25
$9.8B
$321.0M
Q3 25
$9.1B
$326.0M
Q2 25
$9.0B
$331.0M
Q1 25
$8.9B
$335.0M
Q4 24
$8.7B
$340.0M
Q3 24
$8.6B
$345.0M
Q2 24
$8.6B
$351.0M
Q1 24
$8.8B
$356.0M
Stockholders' Equity
DOC
DOC
DRS
DRS
Q4 25
$7.5B
$2.7B
Q3 25
$7.6B
$2.6B
Q2 25
$7.9B
$2.6B
Q1 25
$8.2B
$2.6B
Q4 24
$8.4B
$2.6B
Q3 24
$8.6B
$2.5B
Q2 24
$8.8B
$2.4B
Q1 24
$8.9B
$2.4B
Total Assets
DOC
DOC
DRS
DRS
Q4 25
$20.3B
$4.5B
Q3 25
$19.6B
$4.2B
Q2 25
$19.8B
$4.1B
Q1 25
$19.8B
$4.1B
Q4 24
$19.9B
$4.2B
Q3 24
$20.0B
$3.9B
Q2 24
$20.2B
$3.8B
Q1 24
$20.5B
$3.8B
Debt / Equity
DOC
DOC
DRS
DRS
Q4 25
1.31×
0.12×
Q3 25
1.20×
0.12×
Q2 25
1.14×
0.13×
Q1 25
1.08×
0.13×
Q4 24
1.04×
0.13×
Q3 24
1.00×
0.14×
Q2 24
0.98×
0.15×
Q1 24
0.99×
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
DRS
DRS
Operating Cash FlowLast quarter
$1.3B
$425.0M
Free Cash FlowOCF − Capex
$357.0M
$376.0M
FCF MarginFCF / Revenue
49.6%
35.5%
Capex IntensityCapex / Revenue
124.4%
4.6%
Cash ConversionOCF / Net Profit
10.99×
4.17×
TTM Free Cash FlowTrailing 4 quarters
$227.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
DRS
DRS
Q4 25
$1.3B
$425.0M
Q3 25
$315.0M
$107.0M
Q2 25
$363.5M
$-28.0M
Q1 25
$279.4M
$-138.0M
Q4 24
$1.1B
$443.0M
Q3 24
$318.2M
$59.0M
Q2 24
$316.2M
$34.0M
Q1 24
$152.6M
$-265.0M
Free Cash Flow
DOC
DOC
DRS
DRS
Q4 25
$357.0M
$376.0M
Q3 25
$77.0M
Q2 25
$-56.0M
Q1 25
$-170.0M
Q4 24
$333.7M
$414.0M
Q3 24
$47.0M
Q2 24
$0
Q1 24
$-275.0M
FCF Margin
DOC
DOC
DRS
DRS
Q4 25
49.6%
35.5%
Q3 25
8.0%
Q2 25
-6.8%
Q1 25
-21.3%
Q4 24
47.8%
42.2%
Q3 24
5.8%
Q2 24
0.0%
Q1 24
-40.0%
Capex Intensity
DOC
DOC
DRS
DRS
Q4 25
124.4%
4.6%
Q3 25
3.1%
Q2 25
3.4%
Q1 25
4.0%
Q4 24
105.6%
3.0%
Q3 24
1.5%
Q2 24
4.5%
Q1 24
1.5%
Cash Conversion
DOC
DOC
DRS
DRS
Q4 25
10.99×
4.17×
Q3 25
1.49×
Q2 25
11.48×
-0.52×
Q1 25
6.52×
-2.76×
Q4 24
235.43×
4.98×
Q3 24
3.71×
1.04×
Q2 24
2.17×
0.89×
Q1 24
22.85×
-9.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons